Expertise in
45
conditions

Dr. Victor M. Villalobos

Family Medicine
Mt West Health Center PA
6151 Dew Dr Ste 410, 
El Paso, TX 
Accepting New Patients
Before you request
Expertise in
45
conditions
Mt West Health Center PA
6151 Dew Dr Ste 410, 
El Paso, TX 

Overview

Victor Villalobos is a primary care provider, practicing in Family Medicine in El Paso, Texas.

Dr. Villalobos is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Sitosterolemia, High Cholesterol, Type 2 Diabetes (T2D), and Vitamin D Deficiency.

He is actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 15 clinical trials. Dr. Villalobos is currently accepting new patients.

Specialties

Family Medicine

Licenses

Family Medicine in TX

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
El Paso Health
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Sky Community Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER COMMERCIAL
View 18 Less Insurance Carriers -

Locations

Mt West Health Center PA
6151 Dew Dr Ste 410, El Paso, TX 79912
Other Locations
Office
1550 N Zaragoza Rd Ste A107, El Paso, TX 79936

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Enrollment Status: Completed
Publish Date: August 20, 2026
Intervention Type: Drug
Study Drug: Nirogacestat Oral Tablet
Study Phase: Phase 3
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Drug
Study Drug: Tazemetostat
Study Phase: Phase 2
A Phase II Study of the Peroxisome Proliferator-Activated Receptor Gamma Agonist, Efatutazone in Patients With Previously Treated, Unresectable Myxoid Liposarcoma
A Phase II Study of the Peroxisome Proliferator-Activated Receptor Gamma Agonist, Efatutazone in Patients With Previously Treated, Unresectable Myxoid Liposarcoma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Drug
Study Drug: Efatutazone
Study Phase: Phase 2
An Open-Label, Multi-Center Patient Access Program of Olaratumab for the Treatment of Soft Tissue Sarcoma
An Open-Label, Multi-Center Patient Access Program of Olaratumab for the Treatment of Soft Tissue Sarcoma
Enrollment Status: Approved_for_marketing
Publish Date: December 16, 2024
Intervention Type: Drug
A Non-Randomized, Open-Label, Phase 2 Study of Trametinib in Patients With Unresectable or Metastatic Epithelioid Hemangioendothelioma
A Non-Randomized, Open-Label, Phase 2 Study of Trametinib in Patients With Unresectable or Metastatic Epithelioid Hemangioendothelioma
Enrollment Status: Completed
Publish Date: November 26, 2024
Intervention Type: Other, Drug
Study Drug: Trametinib
Study Phase: Phase 2
A Phase 1, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAB001 in Subjects With Advanced Malignancies
A Phase 1, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAB001 in Subjects With Advanced Malignancies
Enrollment Status: Completed
Publish Date: November 22, 2024
Intervention Type: Biological
Study Drug: Toripalimab, Recombinant Humanized anti-PD-1 Monoclonal Antibody
Study Phase: Phase 1
First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of Axl-specific Antibody-drug Conjugate (Enapotamab Vedotin, HuMax®-AXL-ADC) in Patients With Solid Tumors
First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of Axl-specific Antibody-drug Conjugate (Enapotamab Vedotin, HuMax®-AXL-ADC) in Patients With Solid Tumors
Enrollment Status: Completed
Publish Date: August 01, 2023
Intervention Type: Biological
Study Drug: Enapotamab vedotin 
Study Phase: Phase 1/Phase 2
A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: March 02, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2-3, Multicenter, Randomized, Double-blind Study of Selinexor (KPT-330) Versus Placebo in Patients With Advanced Unresectable Dedifferentiated Liposarcoma (DDLS)
A Phase 2-3, Multicenter, Randomized, Double-blind Study of Selinexor (KPT-330) Versus Placebo in Patients With Advanced Unresectable Dedifferentiated Liposarcoma (DDLS)
Enrollment Status: Completed
Publish Date: January 23, 2023
Intervention Type: Drug
Study Drug: Selinexor
Study Phase: Phase 2/Phase 3
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
Enrollment Status: Completed
Publish Date: October 06, 2022
Intervention Type: Drug
Study Drugs: Avapritinib, Regorafenib
Study Phase: Phase 3
View 9 Less Clinical Trials

32 Total Publications

Trends in Self-Reported Responses to Nutrition Facts Labels Before and After Nutrition Labeling Policy Implementation: A Comparison of Adults in the United States and Mexico.
Trends in Self-Reported Responses to Nutrition Facts Labels Before and After Nutrition Labeling Policy Implementation: A Comparison of Adults in the United States and Mexico.
Journal: Current developments in nutrition
Published: December 18, 2025
Similar Doctors
Expertise in
173
conditions
Dr. Rafael Armendariz
Family Medicine
Expertise in
173
conditions
Dr. Rafael Armendariz
Family Medicine

Office

400 Shadow Mountain Dr, 
El Paso, TX 
 (0.9 miles away)
915-591-2704
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Rafael Armendariz is a primary care provider, practicing in Family Medicine in El Paso, Texas. Dr. Armendariz is highly rated in 173 conditions, according to our data. His clinical expertise encompasses Nephrosclerosis, Renovascular Hypertension, Enlarged Liver, and Type 2 Diabetes (T2D). Dr. Armendariz is currently accepting new patients.

Expertise in
38
conditions
Dr. Douglas D. Alorgbey
Family Medicine | Internal Medicine
Expertise in
38
conditions
Dr. Douglas D. Alorgbey
Family Medicine | Internal Medicine

Hospitalist Medicine Physicians Of Texas PLLC

2001 N Oregon St, Providence Memorial Hospital, 
El Paso, TX 
 (5.8 miles away)
915-577-6011
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients

Douglas Alorgbey is a primary care provider, practicing in Family Medicine and Internal Medicine in El Paso, Texas. Dr. Alorgbey is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Peptic Ulcer, Necrosis, Cellulitis, Gastrostomy, and Myringotomy. Dr. Alorgbey is currently accepting new patients.

Expertise in
48
conditions
Expertise in
48
conditions

Conviva Vista Del Sol

10435 Vista Del Sol Dr, 
El Paso, TX 
 (12.8 miles away)
915-440-3921
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Martha Manquero-Butler is a primary care provider, practicing in Family Medicine in El Paso, Texas. Dr. Manquero-Butler is highly rated in 48 conditions, according to our data. Her clinical expertise encompasses Hypertensive Heart Disease, Necrosis, Type 2 Diabetes (T2D), and Enlarged Liver. Dr. Manquero-Butler is currently accepting new patients.

Frequently Asked Questions about Dr. Victor M. Villalobos

How do I make an appointment with Dr. Victor M. Villalobos?

You can book an appointment with Dr. Victor M. Villalobos by calling their office at 915-584-7920. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Victor M. Villalobos a top-rated expert for Sitosterolemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Victor M. Villalobos is classified as an Distinguished expert for Sitosterolemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Victor M. Villalobos specialize in?

While Dr. Victor M. Villalobos is a Family Medicine, they have specific expertise in Sitosterolemia, High Cholesterol, and Type 2 Diabetes (T2D). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Victor M. Villalobos participate in research or clinical trials?

Yes. Dr. Victor M. Villalobos has published 32 articles and abstracts on conditions like Sitosterolemia. You can view a list of Dr. Victor M. Villalobos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Victor M. Villalobos accept my insurance?

Dr. Victor M. Villalobos accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 915-584-7920 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Villalobos's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 38 Advanced Conditions
    View All 127 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile